Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'low-dose chemotherapy' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 33 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Zagozdzon, R; Golab, J
      Immunomodulation by anticancer chemotherapy: More is not always better (review)

      INTERNATIONAL JOURNAL OF ONCOLOGY
    2. Kersten, MJ; Van Oers, RHJ
      Management of AIDS-Related non-Hodgkin's lymphomas

      DRUGS
    3. Spina, M; Vaccher, E; Juzbasic, S; Milan, I; Nasti, G; Talamini, R; Fasan, M; Antinori, A; Nigra, E; Tirelli, U
      Human immunodeficiency virus-related non-Hodgkin lymphoma - Activity of infusional cyclophosphamide, doxorubicin, and etoposide as second-line chemotherapy in 40 patients

      CANCER
    4. Shamash, J; Walewski, J; Apostolidis, J; Wilson, AM; Foran, JM; Gupta, RK; Rohatiner, AZS; Kelsey, SM; Lister, TA
      Low-dose continuous chemotherapy (LBCMVD-56) for refractory and relapsing lymphoma

      ANNALS OF ONCOLOGY
    5. O'Connor, PG; Scadden, DT
      AIDS oncology

      INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
    6. Rist, CE; Mitznegg, P
      A desmoid tumor mimicking common neck pain

      ONKOLOGIE
    7. Sanz, MA; Martinez, JA; Barragan, E; Martin, G; Lo Coco, F
      All-trans retinoic acid and low-dose chemotherapy for acute promyelocytic leukaemia

      BRITISH JOURNAL OF HAEMATOLOGY
    8. Kaya, H; Nakamura, S; Okafuji, K; Terasaki, Y; Maeno, K; Tanaka, N; Ohtake, S; Matsuda, T
      Trisomy 14 with thrombocytosis and monocytosis

      ACTA HAEMATOLOGICA
    9. Schepetkin, I
      Immune response to haptenized tumor antigen as possible mechanism of anticancer action of hypoxic bioreductive agents at low doses

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    10. Kucera, E; Speiser, P; Gnant, M; Szabo, L; Samonigg, H; Hausmaninger, H; Mittlbock, M; Fridrik, M; Seifert, M; Kubista, E; Reiner, A; Zeillinger, R; Jakesz, R
      Prognostic significance of mutations in the p53 gene, particularly in the zinc-binding domains, in lymph node- and steroid receptor positive breast cancer patients

      EUROPEAN JOURNAL OF CANCER
    11. Cadranel, J; Naccache, JM; Wislez, M; Mayaud, C
      Pulmonary malignancies in the immunocompromised patient

      RESPIRATION
    12. DEMARIO MD; LIEBOWITZ DN
      LYMPHOMAS IN THE IMMUNOCOMPROMISED PATIENT

      Seminars in oncology
    13. MANOHARAN A; BAKER RI; KYLE PW
      LOW-DOSE COMBINATION CHEMOTHERAPY FOR ACUTE MYELOID-LEUKEMIA IN ELDERLY PATIENTS - A NOVEL-APPROACH

      American journal of hematology
    14. AUL C; GATTERMANN N; GERMING U; SUDHOFF T; HOLLMIG KA; HEYLL A
      FATAL HYPERLEUKOCYTIC SYNDROME IN A PATIENT WITH CHRONIC MYELOMONOCYTIC LEUKEMIA

      Leukemia research
    15. SPARANO JA; HU XP; WIERNIK PH; SARTA C; REDDY DM; HANAU L; HENRY DH
      OPPORTUNISTIC INFECTION AND IMMUNOLOGICAL FUNCTION IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS - ASSOCIATED NON-HODGKINS-LYMPHOMA TREATEDWITH CHEMOTHERAPY

      Journal of the National Cancer Institute
    16. TIRELLI U; ERRANTE D; CARBONE A; GLOGHINI A; VACCHER E
      MALIGNANT-LYMPHOMAS IN PATIENTS WITH HIV-INFECTION

      Leukemia & lymphoma
    17. TIRELLI U; ERRANTE D; CARBONE A; GLOGHINI A; VACCHER E
      MALIGNANT-TUMORS IN PATIENTS WITH HIV-INFECTION

      Critical reviews in oncology/hematology
    18. ERRANTE D; VACCHER E; TIRELLI U
      ARE HEMATOPOIETIC COLONY-STIMULATING FACTORS USEFUL IN ASSOCIATION WITH CHEMOTHERAPY IN THE TREATMENT OF HIV-RELATED NON-HODGKINS-LYMPHOMAS

      Annals of oncology
    19. NEWELL M; GOLDSTEIN D; MILLIKEN S; LEWIS C; HOY J; THOMSON B; COOPER D
      PHASE I II TRIAL OF FILGRASTIM (R-METHUG-CSF), CEOP CHEMOTHERAPY AND ANTIRETROVIRAL THERAPY IN HIV-RELATED NON-HODGKINS-LYMPHOMA/

      Annals of oncology
    20. SANDLER AS; KAPLAN LD
      DIAGNOSIS AND MANAGEMENT OF SYSTEMIC NON-HODGKINS-LYMPHOMA IN HIV DISEASE

      Hematology/oncology clinics of North America
    21. JEYASEELAN R; KURABAYASHI M; KEDES L
      DOXORUBICIN INHIBITS TAT-DEPENDENT TRANSACTIVATION OF HIV TYPE-1 LTR

      AIDS research and human retroviruses
    22. SPARANO JA; WIERNIK PH; HU XP; SARTA C; SCHWARTZ EL; SOEIRO R; HENRY DH; MASON B; RATECH H; DUTCHER JP
      PILOT TRIAL OF INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN, AND ETOPOSIDE PLUS DIDANOSINE AND FILGRASTIM IN PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED NON-HODGKINS-LYMPHOMA

      Journal of clinical oncology
    23. TIRELLI U; ERRANTE D; SPINA M; VACCHER E; SERRAINO D; BOIOCCHI M; GLOGHINI A; CARBONE A
      LONG-TERM SURVIVAL OF PATIENTS WITH HIV-RELATED SYSTEMIC NON-HODGKINS-LYMPHOMAS

      Hematological oncology
    24. TIRELLI U; ERRANTE D; SPINA M; GASTALDI R; NIGRA E; NOSARI AM; MAGNANI G; VACCHER E
      2ND-LINE CHEMOTHERAPY IN HUMAN IMMUNODEFICIENCY VIRUS-RELATED NON-HODGKINS-LYMPHOMA - EVIDENCE OF ACTIVITY OF A COMBINATION OF ETOPOSIDE, MITOXANTRONE, AND PREDNIMUSTINE IN RELAPSED PATIENTS

      Cancer
    25. TIRELLI U; SPINA M; VACCHER E; ERRANTE D; TAVIO M; SIMONELLI C; SINICCO A; GASTALDI R; ROSSI G; RIZZARDINI G; FASAN M; BERNARDI D; NASTI G; CARBONE A; SERRAINO D; MONFARDINI S; FOA R
      CLINICAL-EVALUATION OF 451 PATIENTS WITH HIV-RELATED NON-HODGKINS-LYMPHOMA - EXPERIENCE OF THE ITALIAN COOPERATIVE GROUP ON AIDS AND TUMORS(GICAT)

      Leukemia & lymphoma
    26. BERNARDI D; SALVIONI R; VACCHER E; REPETTO L; PIERSANTELLI N; MARINI B; TALAMINI R; TIRELLI U
      TESTICULAR GERM-CELL TUMORS AND HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - A REPORT OF 26 CASES

      Journal of clinical oncology
    27. TOSI P; GHERLINZONI F; VISANI G; CORONADO O; CHIODO F; TURA S
      AZT-GRADE HIV-RELATED NON-HODGKIN LYMPHOMAS - INTERIM-REPORT ON FEASIBILITY AND TOLERANCE(METHOTREXATE IN HIGH)

      Haematologica
    28. GORELIK L; MOKYR MB
      LOW-DOSE-MELPHALAN-INDUCED UP-REGULATION OF TYPE-1 CYTOKINE EXPRESSION IN THE SC TUMOR NODULE OF MOPC-315 TUMOR BEARERS AND THE ROLE OF INTERFERON-GAMMA IN THE THERAPEUTIC OUTCOME

      Cancer immunology and immunotherapy
    29. COOKMILLS JM; MOKYR MB; COHEN RL; PERLMAN RL; CHAMBERS DA
      NEUROTRANSMITTER SUPPRESSION OF THE IN-VITRO GENERATION OF A CYTOTOXIC T-LYMPHOCYTE RESPONSE AGAINST THE SYNGENEIC MOPC-315 PLASMACYTOMA

      Cancer immunology and immunotherapy
    30. TIRELLI U; FRANCESCHI S; CARBONE A
      MALIGNANT-TUMORS IN PATIENTS WITH HIV-INFECTION

      BMJ. British medical journal
    31. GORELIK L; PROKHOROVA A; MOKYR MB
      LOW-DOSE MELPHALAN-INDUCED SHIFT IN THE PRODUCTION OF A TH2-TYPE CYTOKINE TO A TH1-TYPE CYTOKINE IN MICE BEARING A LARGE MOPC-315 TUMOR

      Cancer immunology and immunotherapy
    32. WEISKIRCH LM; BARDAGAN Y; MOKYR MB
      TRANSFORMING GROWTH FACTOR-BETA-MEDIATED DOWN-REGULATION OF ANTITUMORCYTOTOXICITY OF SPLEEN-CELLS FROM MOPC-315 TUMOR-BEARING MICE ENGAGEDIN TUMOR-ERADICATION FOLLOWING LOW-DOSE MELPHALAN THERAPY

      Cancer immunology and immunotherapy
    33. MONFARDINI S; TIRELLI U; VACCHER E
      TREATMENT OF ACQUIRED-IMMUNODEFICIENCY-SYNDROME (AIDS)-RELATED CANCER

      Cancer treatment reviews


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 01/06/20 alle ore 23:00:34